Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Balzarini

Showing results (1-10 of 563) with videos related to

Pageof 57
Sort By:
Current Topics in Medicinal Chemistry|May 12, 2004
Current status of the non-nucleoside reverse transcriptase inhibitors of human immunodeficiency virus type 1J Balzarini
Pharmacy World & Science : PWS|April 15, 1994
Metabolism and mechanism of antiretroviral action of purine and pyrimidine derivativesJ Balzarini
Pharmacology & Therapeutics|September 29, 2000
Effect of antimetabolite drugs of nucleotide metabolism on the anti-human immunodeficiency virus activity of nucleoside reverse transcriptase inhibitorsJ Balzarini
Verhandelingen - Koninklijke Academie Voor Geneeskunde Van Belgie|January 1, 1991
[Anti-retroviral activity and molecular-biochemical action mechanism of 2',3'-dideoxynucleoside analogs and 9-(2-phosphonylmethoxyethyl) purine derivatives]J Balzarini
Advances in Experimental Medicine and Biology|January 1, 1994
Anti-retroviral and pharmacological properties of 9-(2-phosphonylmethoxyethyl) adenine (PMEA)J Balzarini
Verhandelingen - Koninklijke Academie Voor Geneeskunde Van Belgie|January 1, 1995
Novel concepts in the treatment of human immunodeficiency virus type 1 (HIV-1) infections by HIV-1-specific reverse transcriptase inhibitorsJ Balzarini
Bulletin Et Memoires De L'Academie Royale De Medecine De Belgique|January 1, 1985
Role of thymidylate synthetase in the cytostatic activity of pyrimidine nucleoside analoguesJ Balzarini
Methods in Molecular Medicine|February 19, 2011
Evaluation of Compounds Against Recombinant HIV Reverse TranscriptaseJ Balzarini
Biochemical Pharmacology|July 14, 1999
Suppression of resistance to drugs targeted to human immunodeficiency virus reverse transcriptase by combination therapyJ Balzarini
Antiviral Research|March 30, 2006
Inhibition of HIV entry by carbohydrate-binding proteinsJ Balzarini
Pageof 57

Showing results (1-10 of 563) with videos related to

Sort By:
Pageof 57
Current Topics in Medicinal Chemistry|May 12, 2004
Current status of the non-nucleoside reverse transcriptase inhibitors of human immunodeficiency virus type 1J Balzarini
Pharmacy World & Science : PWS|April 15, 1994
Metabolism and mechanism of antiretroviral action of purine and pyrimidine derivativesJ Balzarini
Pharmacology & Therapeutics|September 29, 2000
Effect of antimetabolite drugs of nucleotide metabolism on the anti-human immunodeficiency virus activity of nucleoside reverse transcriptase inhibitorsJ Balzarini
Verhandelingen - Koninklijke Academie Voor Geneeskunde Van Belgie|January 1, 1991
[Anti-retroviral activity and molecular-biochemical action mechanism of 2',3'-dideoxynucleoside analogs and 9-(2-phosphonylmethoxyethyl) purine derivatives]J Balzarini
Advances in Experimental Medicine and Biology|January 1, 1994
Anti-retroviral and pharmacological properties of 9-(2-phosphonylmethoxyethyl) adenine (PMEA)J Balzarini
Verhandelingen - Koninklijke Academie Voor Geneeskunde Van Belgie|January 1, 1995
Novel concepts in the treatment of human immunodeficiency virus type 1 (HIV-1) infections by HIV-1-specific reverse transcriptase inhibitorsJ Balzarini
Bulletin Et Memoires De L'Academie Royale De Medecine De Belgique|January 1, 1985
Role of thymidylate synthetase in the cytostatic activity of pyrimidine nucleoside analoguesJ Balzarini
Methods in Molecular Medicine|February 19, 2011
Evaluation of Compounds Against Recombinant HIV Reverse TranscriptaseJ Balzarini
Biochemical Pharmacology|July 14, 1999
Suppression of resistance to drugs targeted to human immunodeficiency virus reverse transcriptase by combination therapyJ Balzarini
Antiviral Research|March 30, 2006
Inhibition of HIV entry by carbohydrate-binding proteinsJ Balzarini
Pageof 57